Quick Overview: Understanding the Pathway article: The Journal of Clinical Oncology's ... Aditya Bardia, MD, MPH, attending physician, Massachusetts General Hospital, Harvard Medical School, discusses the Panelists Adam M. Brufsky, MD, PhD; Kimberly L. Blackwell, MD; Mark E. Robson, MD; and Aditya Bardia, MD, MPH, highlight the ...
Two Dimensions In Targeting Her2 - Detailed Overview & Context
Understanding the Pathway article: The Journal of Clinical Oncology's ... Aditya Bardia, MD, MPH, attending physician, Massachusetts General Hospital, Harvard Medical School, discusses the Panelists Adam M. Brufsky, MD, PhD; Kimberly L. Blackwell, MD; Mark E. Robson, MD; and Aditya Bardia, MD, MPH, highlight the ... Dr. Justin Gainor discusses why it has been difficult to treat the For more info, visit: This video explains Earn CME for related activities: Patients whose disease progresses or relapses on trastuzumab now ...
Sarah A. Hurvitz, MD, explores the history of Genentech VP of Clinical Oncology Dietmar Berger discusses the role of the Sunil Verma, MD, MSEd, FRCPC, associate professor, University of Toronto, chair, Breast Medical Oncology, Sunnybrook Odette ... Erika P. Hamilton, MD, director of the Breast and Gynecologic Research Program at Sarah Cannon Research Institute, discusses ... William J. Gradishar, MD, Northwestern University Feinberg School of Medicine, shares his expert insights on the evolving ... Erika Hamilton, MD, Sarah Cannon Research Institute, Nashville, TN, reflects on the expanding treatment landscape of ...
Nathan A. Pennell, MD, PhD, an associate professor in the Department of Medicine and director of the Lung Cancer Medical ... Martine Piccart, MD, PhD, Université Libre de Bruxelles, Brussels, Belgium, talks on the updated 6-year follow-up results from the ... Dr. Jing Xi, medical oncologist at Rocky Mountain Breast Specialists, discusses what Ruth O'Regan, MD, reviews the case of a 49-year-old female patient with
